Aflac 10-Q 2021-09-30
Filed 2021-10-28. 6 sections, 578K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2021
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-07434

Aflac Incorporated
_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
(Exact name of registrant as specified in its charter)
| Georgia | 58-1167100 | |||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| 1932 Wynnton Road | Columbus, | Georgia | 31999 | |||||||||||
| (Address of principal executive offices) | (ZIP Code) |
- 323.3431
(Registrant's telephone number, including area code)
| (Former name, former address and former fiscal year, if changed since last report) |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Common Stock, $.10 par value per share | AFL | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). þ Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | þ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ¨ | Smaller reporting company | ☐ | ||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes þ No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. 661,528,219 shares of the issuer's common stock were outstanding as of October 19, 2021.
Aflac Incorporated and Subsidiaries
Quarterly Report on Form 10-Q
For the Quarter Ended September 30, 2021
Table of Contents
Items other than those listed above are omitted because they are not required or are not applicable.
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
Aflac Incorporated and Subsidiaries
Consolidated Statements of Earnings
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| (In millions, except for share and per-share amounts - Unaudited) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||
| Revenues: | ||||||||||||||||||||||||||||||||||||||
| Net premiums, principally supplemental health insurance | $ | 4,372 | $ | 4,623 | $ | 13,406 | $ | 13,969 | ||||||||||||||||||||||||||||||
| Net investment income | 991 | 896 | 2,908 | 2,669 | ||||||||||||||||||||||||||||||||||
| Net investment gains (losses) | (171) | 108 | 224 | (525) | ||||||||||||||||||||||||||||||||||
| Other income (loss) | 45 | 38 | 132 | 121 | ||||||||||||||||||||||||||||||||||
| Total revenues | 5,237 | 5,665 | 16,670 | 16,234 | ||||||||||||||||||||||||||||||||||
| Benefits and expenses: | ||||||||||||||||||||||||||||||||||||||
| Benefits and claims, net | 2,609 | 2,985 | 7,996 | 8,822 | ||||||||||||||||||||||||||||||||||
| Acquisition and operating expenses: | ||||||||||||||||||||||||||||||||||||||
| Amortization of deferred policy acquisition costs | 278 | 292 | 869 | 914 | ||||||||||||||||||||||||||||||||||
| Insurance commissions | 311 | 325 | 952 | 993 | ||||||||||||||||||||||||||||||||||
| Insurance and other expenses (1) | 869 | 847 | 2,582 | 2,382 | ||||||||||||||||||||||||||||||||||
| Interest expense | 57 | 63 | 181 | 181 | ||||||||||||||||||||||||||||||||||
| Total acquisition and operating expenses | 1,515 | 1,527 | 4,584 | 4,470 | ||||||||||||||||||||||||||||||||||
| Total benefits and expenses | 4,124 | 4,512 | 12,580 | 13,292 | ||||||||||||||||||||||||||||||||||
| Earnings before income taxes | 1,113 | 1,153 | 4,090 | 2,942 | ||||||||||||||||||||||||||||||||||
| Income taxes | 225 | (1,303) | 804 | (884) | ||||||||||||||||||||||||||||||||||
| Net earnings | $ | 888 | $ | 2,456 | $ | 3,286 | $ | 3,826 | ||||||||||||||||||||||||||||||
| Net earnings per share: | ||||||||||||||||||||||||||||||||||||||
| Basic | $ | 1.33 | $ | 3.45 | $ | 4.84 | $ | 5.33 | ||||||||||||||||||||||||||||||
| Diluted | 1.32 | 3.44 | 4.82 | 5.31 | ||||||||||||||||||||||||||||||||||
| Weighted-average outstanding common shares used in computing earnings per share (In thousands): | ||||||||||||||||||||||||||||||||||||||
| Basic | 668,762 | 711,698 | 678,509 | 717,962 | ||||||||||||||||||||||||||||||||||
| Diluted | 671,925 | 713,793 | 681,521 | 720,333 | ||||||||||||||||||||||||||||||||||
| Cash dividends per share | $ | .33 | $ | .28 | $ | .99 | $ | .84 |
(1) Includes expense of $48 and $15 for the nine-month periods ended September 30, 2021 and 2020, respectively, for the early extinguishment of debt.
See the accompanying Notes to the Consolidated Financial Statements.
Aflac Incorporated and Subsidiaries
Consolidated Statements of Comprehensive Income (Loss)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| (In millions - Unaudited) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||
| Net earnings | $ | 888 | $ | 2,456 | $ | 3,286 | $ | 3,826 | ||||||||||||||||||||||||||||||
| Other comprehensive income (loss) before income taxes: | ||||||||||||||||||||||||||||||||||||||
| Unrealized foreign currency translation gains (losses) during period | (93) | 172 | (646) | 329 | ||||||||||||||||||||||||||||||||||
| Unrealized gains (losses) on fixed maturity securities: | ||||||||||||||||||||||||||||||||||||||
| Unrealized holding gains (losses) on fixed maturity securities during period | (316) | 1,420 | (800) | 26 | ||||||||||||||||||||||||||||||||||
| Reclassification adjustment for (gains) losses on fixed maturity securities included in net earnings | (13) | (13) | 2 | 132 | ||||||||||||||||||||||||||||||||||
| Unrealized gains (losses) on derivatives during period | 2 | 2 | 3 | (3) | ||||||||||||||||||||||||||||||||||
| Pension liability adjustment during period | 1 | (1) | 7 | (1) | ||||||||||||||||||||||||||||||||||
| Total other comprehensive income (loss) before income taxes | (419) | 1,580 | (1,434) | 483 | ||||||||||||||||||||||||||||||||||
| Income tax expense (benefit) related to items of other comprehensive income (loss) | (62) | 413 | (162) |
Showing the first 8K of 369K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A)
FORWARD-LOOKING INFORMATION
The Private Securities Litigation Reform Act of 1995 provides a safe harbor to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. Aflac Incorporated (the Parent Company) and its subsidiaries (collectively with the Parent Company, the Company) desire to take advantage of these provisions. This report contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as the ones listed below or similar words, as well as specific projections of future results, generally qualify as forward-looking. The Company undertakes no obligation to update such forward-looking statements.
| • expect | • anticipate | • believe | • goal | • objective | ||||||||||
| • may | • should | • estimate | • intends | • projects | ||||||||||
| • will | • assumes | • potential | • target | • outlook |
The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:
-
difficult conditions in global capital markets and the economy, including those caused by COVID-19
-
defaults and credit downgrades of investments
-
exposure to significant interest rate risk
-
concentration of business in Japan
-
limited availability of acceptable yen-denominated investments
-
foreign currency fluctuations in the yen/dollar exchange rate
-
differing judgments applied to investment valuations
-
significant valuation judgments in determination of expected credit losses recorded on the Company's investments
-
decreases in the Company's financial strength or debt ratings
-
decline in creditworthiness of other financial institutions
-
concentration of the Company's investments in any particular single-issuer or sector
-
the effects of COVID-19 and its variants (both known and emerging), and any resulting economic effects and government interventions, on the Company's business and financial results
-
ability to attract and retain qualified sales associates, brokers, employees, and distribution partners
-
deviations in actual experience from pricing and reserving assumptions
-
ability to continue to develop and implement improvements in information technology systems
-
interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems
-
subsidiaries' ability to pay dividends to the Parent Company
-
inherent limitations to risk management policies and procedures
-
the level of sales of Aflac Japan products in the Japan Post channel
-
tax rates applicable to the Company may change
-
failure to comply with restrictions on policyholder privacy and information security
-
extensive regulation and changes in law or regulation by governmental authorities
-
competitive environment and ability to anticipate and respond to market trends
-
catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as the coronavirus COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events
-
ability to protect the Aflac brand and the Company's reputation
-
ability to effectively manage key executive succession
-
changes in accounting standards
-
level and outcome of litigation
-
allegations or determinations of worker misclassification in the United States
MD&A OVERVIEW
MD&A is intended to inform the reader about matters affecting the financial condition and results of operations of Aflac Incorporated and its subsidiaries for the nine-month periods ended September 30, 2021 and 2020, respectively. Results of operations for interim periods are not necessarily indicative of results for the entire year. As a result, the following discussion should be read in conjunction with the consolidated financial statements and notes that are included in the Company's annual report on Form 10-K for the year ended December 31, 2020 (2020 Annual Report). In this MD&A, amounts may not foot due to rounding. For additional information on the Company’s performance measures included in this MD&A, see the Glossary of Selected Terms found directly following Part II. Other Information.
This MD&A is divided into the following sections:
EXECUTIVE SUMMARY
Company Overview
Aflac Incorporated (the Parent Company) and its subsidiaries (collectively, the Company) provide financial protection to more than 50 million people worldwide. The Company’s principal business is supplemental health and life insurance products with the goal to provide customers the best value in supplemental insurance products in the United States (U.S.) and Japan. The Company's insurance business consists of two reporting segments: Aflac Japan and Aflac U.S. The Parent Company’s primary insurance subsidiaries are Aflac Life Insurance Japan Ltd. in Japan (Aflac Japan) and American Family Life Assurance Company of Columbus (Aflac); Continental American Insurance Company (CAIC), branded as Aflac Group Insurance (AGI); American Family Life Assurance Company of New York (Aflac New York); Tier One Insurance Company (TOIC) and Argus Dental & Vision, Inc. (Argus), which provides a platform for Aflac Dental and Vision in the U.S. (collectively, Aflac U.S.).
COVID-19
The impact of the
Showing the first 8K of 182K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures about Market Risk
The Company is exposed primarily to the following types of market risks: currency risk, interest rate risk, credit risk and equity risk. The Company regularly monitors its market risks and uses a variety of strategies to manage its exposure to these market risks. A description of the Company's market risk exposures may be found under “Quantitative and Qualitative Disclosures About Market Risk” in Part II, Item 7A, of the 2020 Annual Report. There have been no changes to the Company's market risk exposures from the market risk exposures previously disclosed in the 2020 Annual Report except as outlined below.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of the end of the period covered by this quarterly report (the Evaluation Date). Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
During the first nine months of 2021, the Company has executed internal controls associated with new processes supporting the implementation of Accounting Standards Update (ASU) 2018-12 for long-duration insurance contracts (LDTI). These controls provide assurance over the reasonableness of the estimated range of impact to the Company's accumulated other comprehensive income (AOCI) that is expected upon adoption of LDTI on January 1, 2023 as disclosed in Note 1 of the Notes to the Consolidated Financial Statements. The Company will continue to refine and maturate the internal controls associated with LDTI until adoption on January 1, 2023. Except for the change in controls over the Company's implementation of LDTI, there have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) during the third fiscal quarter of 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
**Item 2.**Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
During the first nine months of 2021, the Company repurchased shares of its common stock as follows:
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||||
| January 1 - January 31 | 2,850,664 | $ | 45.60 | 2,850,664 | 96,304,954 | |||||||||||||||||||||
| February 1 - February 28 | 5,034,979 | 47.30 | 4,661,812 | 91,643,142 | ||||||||||||||||||||||
| March 1 - March 31 | 5,932,047 | 50.55 | 5,927,500 | 85,715,642 | ||||||||||||||||||||||
| April 1 - April 30 | 2,266,200 | 52.73 | 2,266,200 | 83,449,442 | ||||||||||||||||||||||
| May 1 - May 31 | 2,855,900 | 55.81 | 2,855,900 | 80,593,542 | ||||||||||||||||||||||
| June 1 - June 30 | 4,055,001 | 54.61 | 4,052,204 | 76,541,338 | ||||||||||||||||||||||
| July 1 - July 31 | 2,436,400 | 53.51 | 2,436,400 | 74,104,938 | ||||||||||||||||||||||
| August 1 - August 31 | 3,706,404 | 56.51 | 3,675,122 | 70,429,816 | ||||||||||||||||||||||
| September 1 - September 30 | 3,467,904 | 54.09 | 3,460,300 | 66,969,516 | ||||||||||||||||||||||
| Total | 32,605,499 | (1) | $ | 52.01 | 32,186,102 | 66,969,516 |
(1) During the first nine months of 2021, 419,397 shares were purchased in connection with income tax withholding obligations related to the vesting of restricted-share-based awards during the period.
Item 6. Exhibits
| (a) | EXHIBIT INDEX | |||||||||||||
| 3.0 | - | Articles of Incorporation, as amended – incorporated by reference from Form 10-Q for June 30, 2008, Exhibit 3.0. | ||||||||||||
| 3.1 | - | Bylaws of the Corporation, as amended and restated – incorporated by reference from Form 8-K dated April 6, 2020, Exhibit 3.1. | ||||||||||||
| 31.1 | - | Certification of CEO dated October 28, 2021, required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934. | ||||||||||||
| 31.2 | - | Certification of CFO dated October 28, 2021, required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934. | ||||||||||||
| 32 | - | Certification of CEO and CFO dated October 28, 2021, pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||||
| 101.INS | - | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||||
| 101.SCH | - | Inline XBRL Taxonomy Extension Schema. | ||||||||||||
| 101.CAL | - | Inline XBRL Taxonomy Extension Calculation Linkbase. | ||||||||||||
| 101.DEF | - | Inline XBRL Taxonomy Extension Definition Linkbase. | ||||||||||||
| 101.LAB | - | Inline XBRL Taxonomy Extension Label Linkbase. | ||||||||||||
| 101.PRE | - | Inline XBRL Taxonomy Extension Presentation Linkbase. | ||||||||||||
| 104 | - | Cover Page Interactive Data File - formatted as Inline XBRL and contained in Exhibit 101. |
Defined Terms
Throughout this Quarterly Report on Form 10-Q, the Company may use abbreviations, acronyms and defined terms which are defined below.
| ALM | Asset-Liability Matching | ||||
| AOCI | Accumulated Other Comprehensive Income | ||||
| ARP | American Rescue Plan | ||||
| ASC | Accounting Standards Codification | ||||
| ASU | Accounting Standards Update | ||||
| CARES | Coronavirus Aid, Relief, and Economic Security | ||||
| CDS | Credit Default Swap | ||||
| CMLs | Commercial Mortgage Loans | ||||
| CSAs | Credit Support Annexes | ||||
| DAC | Deferred Policy Acquisition Costs | ||||
| DSCR | Debt Service Coverage Ratios | ||||
| EPS | Earnings Per Share | ||||
| FASB | Financial Accounting Standard Boards | ||||
| FHLB | Federal Home Loan Bank of Atlanta | ||||
| FSA | Japanese Financial Services Agency | ||||
| ISDA | International Swaps and Derivatives Association, Inc. | ||||
| ISOs | Incentive Stock Options | ||||
| JGB | Japan Government Bond | ||||
| LDTI | Long-Duration Targeted Improvements | ||||
| LGD | Loss-Given-Default | ||||
| LIBOR | London Interbank Offered Rate | ||||
| LIPPC | Life Insurance Policyholder Protection Corporation | ||||
| LTV | Loan-to-Value | ||||
| MD&A | Management's Discussion and Analysis of Financial Condition and Results of Operations | ||||
| MMLs | Middle Market Loans | ||||
| NAIC | National Association of Insurance Commissioners | ||||
| NOLHGA | National Organization of Life and Health Guaranty Associations | ||||
| NQSOs | Non-qualifying Stock Options | ||||
| NRSROs | Nationally Recognized Statistical Rating Organizations | ||||
| OTC | Over-the-Counter | ||||
| PD | Probability-of-Default | ||||
| PRM | Policy Reserve Matching | ||||
| RBC | Risk-Based Capital | ||||
| ROE | Return on Equity | ||||
| S&P | Standard & Poor's | ||||
| SEC | Securities and Exchange Commission | ||||
| SMR | Solvency Margin Ratio | ||||
| The Plan | Aflac Incorporated Long-Term Incentive Plan | ||||
| TIBOR | Tokyo Interbank Market Rate | ||||
| TDRs | Troubled Debt Restructurings | ||||
| TREs | Transitional Real Estate Loans | ||||
| TTM | Telegraphic Transfer Middle Rate | ||||
| U.S. GAAP | U.S. Generally Accepted Accounting Principles | ||||
| VIEs | Variable Interest Entities |
Glossary of Selected Terms
Throughout this Quarterly Report on Form 10-Q, the Company may use certain performance metrics and other terms which are defined below.
Adjusted Net Investment Income - Net Investment Income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity and ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and (losses) to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company's investments and related hedging strategies. The metric is used in segment reporting as a component of segment profitability.
Affiliated Corporate Agency – Agency in Japan directly affiliated with a specific corporation that sells insurance policies primarily to its employees.
Annualized Premiums in Force – the amount of gross premium that a policyholder must pay over a full year in order to keep coverage. The growth of net premiums (defined below) is directly affected by the change in premiums in force and by the change in weighted-average yen/dollar exchange rates.
Average Weekly Producer – The total number of writing agents who have produced greater than $0.00 during the production week - excluding any manual adjustments divided by the number of weeks in the time period. The Company believes this metric allows sales management to monitor progress and needs, as well as serve as a leading indicator of future production capacity.
Capital Buffer – Established dollar amount of liquidity at the Parent Company reserved for injecting capital into the insurance entities or general liquidity support for general expenses at the Parent Company. Currently, the capital buffer is $1.0 billion and is part of $2.0 billion minimum balance at the Parent Company.
Earnings Per Basic Share – Net earnings divided by weighted-average number of shares outstanding for the period.
Earnings Per Diluted Share – Net earnings divided by the weighted-average number of shares outstanding for the period plus the weighted-average shares for the dilutive effect of share-based awards outstanding.
Group Insurance – Insurance issued to a group, such as an employer or trade association, that covers
employees or association members and their dependents through certificates of coverage.
Individual Insurance – Insurance issued to an individual with the policy designed to cover that person and his or her dependents.
In-force Policies – A count of policies that are active contracts at the end of a period.
Liquidity Support – Internally defined and established dollar amount of liquidity reserved for supporting potential collateral and settlements of derivatives at the Parent Company. Currently, the liquidity support is $1.0 billion and is part of the $2.0 billion minimum balance at the Parent Company.
Net Investment Income – The income derived from interest and dividends on invested assets, after deducting investment expenses.
Net Premiums – (sometimes referred to as net premium income or net earned premiums) is a financial measure that appears on the Company's Consolidated Statements of Earnings and in its segment reporting. This measure reflects collected or due premiums that have been earned ratably on policies in force during the reporting period, reduced by premiums that have been ceded to third parties and increased by premiums assumed through reinsurance.
New Annualized Premium Sales – (sometimes referred to as new sales or sales) An operating measure that is not reflected on the Company's financial statements. New annualized premium sales generally represent annual premiums on policies the Company sold and incremental increases from policy conversions that would be collected over a 12-month period assuming the policies remain in force for that entire period. For Aflac Japan, new annualized premium sales are determined by applications submitted during the reporting period. For Aflac U.S., new annualized premium sales are determined by applications. that are issued during the reporting period. Policy conversions are defined as the positive difference in the annualized premium when a policy upgrades in the current reporting period.
New Money Yield – Gross yields earned on purchases of fixed maturities, loan receivables, and equities. Purchases exclude capitalized interest, securities lending/repurchase agreements, short-term/cash activity, and alternatives. New money yield for equities is based on the assumed dividend yield at the time of purchase. The new money yield for Aflac Japan excludes the impact of any derivatives and associated amortized hedge costs associated with USD-denominated investments. Management uses this metric as a leading indicator of future investment earning potential.
Operating Ratios – Used to evaluate the Company's financial condition and profitability. Examples include: (1) Ratios to total adjusted revenues, which present expenses as a percentage of total revenues and (2) Ratios to total premium, including benefit ratio.
Persistency – Percentage of premiums remaining in force at the end of a period, usually one year. For example, 95% persistency would mean that 95% of the premiums in force at the beginning of the period were still in force at the end of the period.
Pretax Adjusted Earnings – Earnings as adjusted earnings before the application of income taxes. This measure is used in the Company's segment reporting.
Pretax Adjusted Profit Margin – Adjusted earnings divided by adjusted revenues, before taxes are applied. This measure is used in the Company's segment reporting.
Return on Average Invested Assets – Net investment income as a percentage of average invested assets during the period. Management uses this metric to demonstrate how our actual net investment income results represent an overall return on the portfolio to provide a more comparative metric as the size of our investment portfolio changes over time.
Risk-based Capital (RBC) Ratio – Statutory adjusted capital divided by statutory required capital. This insurance ratio is based on rules prescribed by the National Association of Insurance Commissioners (NAIC) and provides an indication of the amount of statutory capital the insurance company maintains, relative to the inherent risks in the insurer’s operations.
Solvency Margin Ratio (SMR) – Solvency margin total divided by one half of the risk total. This insurance ratio is prescribed by the Japan Financial Services Agency (FSA) and is used for all life insurance companies in Japan to measure the adequacy of the company’s ability to pay policyholder claims in the event actual risks exceed expected levels.
Statutory Earnings – Earnings determined according to accounting rules prescribed by the National Association of Insurance Commissioners (NAIC), as modified by the insurance department in the insurance company’s state of domicile. These statutory accounting rules are different from U.S. GAAP and are intended to emphasize policyholder protection and company solvency.
Weighted-Average Foreign Currency Exchange Rate – Japan segment operating earnings for the period (excluding hedge costs) in yen divided by Japan segment operating earnings for the period (excluding hedge costs) in dollars. Management uses this metric to evaluate and determine consolidated results on foreign currency effective basis.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Aflac Incorporated | ||||||||
| October 28, 2021 | /s/ Max K. Brodén | |||||||
| (Max K. Brodén) | ||||||||
| Executive Vice President; Chief Financial Officer and Treasurer | ||||||||
| October 28, 2021 | /s/ June Howard | |||||||
| (June Howard) | ||||||||
| Senior Vice President, Financial Services; Chief Accounting Officer |